Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2024
If smoking was limited to 20 years, more cancers could be detected and disparities would disappear.
Read Full NewsThe HCPFive: Top News for Healthcare Providers from the Week of 10/25
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.
Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.
Here's some of what is coming soon to NeurologyLive® this week.
Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
1.
FDA approves rivanetin as the first-line treatment for lung cancer.
2.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
5.
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma
1.
Virtual Oncology Follow-Up: Current Practices, Evidence, and Clinical Implications
2.
Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy
3.
Population Surveillance of Environmental Cancer Risk Clusters
4.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
5.
Therapeutic Advances in Tumor Calcium-Signaling Modulation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Navigating the Complexities of Ph Negative ALL - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge